IMU Biosciences is a Biotech company based in London, United Kingdom. It has raised $166M in total funding. Latest round: Series A.
IMU Biosciences is a Biotech company based in London, United Kingdom. IMU Biosciences has raised $166M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in June 2026. The round record for IMU Biosciences runs through 2026; nothing later has been disclosed. Investors on record include IQ Capital, Molten Ventures, British Business Bank, Meltwind, Kfund, LifeX Ventures. 6 distinct backers are named across the disclosed rounds.
Totals shown for IMU Biosciences aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in London and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026